What does an Expanded Access Program mean for GIST patients?
Pharmaceutical companies may create an Expanded Access Program (sometimes called compassionate use) when a clinical trial is no longer enrolling but the medicine still shows promise.
GIST & Clinical Trials – LRG Canada
GIST Sarcoma LRG Canada is hosting a webinar on clinical trials in GIST on Saturday May 24 at 1pm.
Clinical Trials & Nutrition
Nutrition is important to keep in mind during any cancer treatment, but especially during a clinical trial.
Clinical Trials Wednesday – Kandee Evans Shares
GISTer Kandee Evans openly shares her experiences as a new clinical trial participant in the StrateGIST 1 trial sponsored by IDRx.
Demystifying Clinical Trials
Dr. Candace Haddox of Dana-Farber Cancer Institute will offer invaluable insights into the world of clinical trials in honor of International Clinical Trials Awareness Day as well as discussing trials with GIST Advocate Kandee Evans
Clinical Trial for Ripretinib
Studies have shown that if you have GIST with mutations in KIT exons 11 and 17/18, ripretinib may be a better option for second-line treatment than the standard sunitinib.
Gaining Insight on the INSIGHT Phase 3 Study
Dr. Neeta Somaiah, MD Anderson Cancer, Center will present “Gaining Insight on the INSIGHT Phase 3 Study” for the GIST community on April 11, 2024.
What are Clinical Trials & How Do You Find Them?
Clinical trials are scientific research studies done in humans that help us to understand whether a new treatment is safe and effective in treating an illness, such as cancer.
New Clinical Trials Focus for the LRG in 2024
Starting in January, every Wednesday will be dedicated learning about clinical trial process and to highlighting the groundbreaking clinical trials focused on gastrointestinal stromal tumors (GIST).
Understanding GIST Mutations & Clinical Trials Update
In this session of Let's Get the GIST of It, we will be reviewing GIST mutations and sharing the current updates on GIST Clinical Trials.